GlassScriptPhysician profile
Dawn Salvatore
NPI 1033204805
$4,875.55
in general payments reported to CMS, 2019-2025
11 companies · $1,078 in 2025
The $1,078 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $762 · 2020: $363 · 2021: $176 · 2022: $1,143 · 2023: $569 · 2024: $783 · 2025: $1,078.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,430.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $2,400.72 | 2019-2025 | Zenith Spiral-Z, Zilver Ptx, Icast Covered Stent System, 6mmx22mmx120cm |
| W. L. Gore & Associates, INC. | $812.51 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Boston Scientific Corporation | $516.07 | 2023-2025 | Eluvia, Enroute Transcarotid Neuroprotection System |
| Medtronic Vascular, INC. | $400.84 | 2019-2020 | |
| Silk Road Medical, INC. | $226.82 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Medtronic, INC. | $170.75 | 2022-2025 | Endurant Iis |
| Penumbra, INC. | $153.32 | 2022 | |
| Kci USA, INC. | $87.14 | 2022 | |
| Inari Medical, INC. | $60.70 | 2022 | |
| Lemaitre Vascular, INC. | $34.38 | 2022 | |
| Baxter Healthcare | $12.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Salvatore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.